The WEB-IT pivotal trial highlights positive clinical outcomes with the WEB® Aneurysm Embolization System, the only intrasaccular flow disruptor approved in the United States.
PR Newswire
ALISO VIEJO, Calif., April 18, 2019
PR Newswire
ALISO VIEJO, Calif., April 18, 2019
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey